SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001213900-21-026695
Filing Date
2021-05-17
Accepted
2021-05-17 08:08:25
Documents
1
Period of Report
2021-03-31
Effectiveness Date
2021-05-17

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea141015-nt10q_rasnathera.htm NT 10-Q 16494
  Complete submission text file 0001213900-21-026695.txt   17649
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: NT 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 21927686
SIC: 2834 Pharmaceutical Preparations